Learn

Saturday, 21 November

FMGE · blueprint and recall

FMGE Anticancer drugs

Candidates recalled anticancer drugs from 14 of the 19 FMGE sessions in this collection, including 10 of the 11 well-covered ones. It first appears in FMGE Jun 2009 and last in FMGE Jan 2026. 10 of its 13 recalled concepts came as one-liners.

Concepts in recalled topics
13
unofficial
Sessions seen in
14
Well-covered sessions
10
with this topic recorded
Image-linked concepts
0

Recurrence in this collection

Each recalled session counts once for this topic, even if it contains several related concepts.

Seen in 14 of the 19 sessions with recall; 10 of the 11 well-covered sessions.

First seen: FMGE Jun 2009. Last seen: FMGE Jan 2026.

First and last seen refer to this recall collection only. Thin coverage limits what absence can tell you. Read the method.

Question styles and image links

Question styles in the recall

one-liner
10 concepts · 76.9%
vignette
3 concepts · 23.1%

Within this topic

Finer labels from the unofficial recall, grouped under Lumi's outline topic.

Subtopics represented

  • Bleomycin toxicity
  • Haematopoietic growth factors
  • Platinum compounds
  • Methotrexate
  • Targeted therapy
  • Anticancer toxicity

Image types recorded

No concepts recorded in this category.

Image-type percentages use all 13 concepts in this topic as the denominator. The labels describe images in recall; no images are reproduced.

Related topics in this chapter

  • Chemotherapy

    Antimalarials and anthelmintics

    Seen in 6 of the 19 sessions with recall; 5 of the 11 well-covered sessions.

    First seen: FMGE Jun 2009. Last seen: FMGE Jul 2025.

    Styles: one-liner (4) · vignette (1).

  • Chemotherapy

    Fluoroquinolones and others

    Seen in 5 of the 19 sessions with recall; 4 of the 11 well-covered sessions.

    First seen: FMGE Dec 2010. Last seen: FMGE Jul 2025.

    Styles: one-liner (6) · vignette (1).

  • Chemotherapy

    Antifungals

    Seen in 4 of the 19 sessions with recall; 3 of the 11 well-covered sessions.

    First seen: FMGE Jun 2011. Last seen: FMGE Jul 2025.

    Styles: one-liner (1) · vignette (1).

  • Chemotherapy

    Antivirals

    Seen in 3 of the 19 sessions with recall; 3 of the 11 well-covered sessions.

    First seen: FMGE Jun 2009. Last seen: FMGE Dec 2020.

    Styles: one-liner (3) · image + vignette (1).

  • Chemotherapy

    Aminoglycosides, macrolides and tetracyclines

    Seen in 3 of the 19 sessions with recall; 2 of the 11 well-covered sessions.

    First seen: FMGE Dec 2011. Last seen: FMGE Jan 2025.

    Styles: one-liner (3).

  • Chemotherapy

    Beta-lactams

    Seen in 2 of the 19 sessions with recall; 2 of the 11 well-covered sessions.

    First seen: FMGE Jun 2019. Last seen: FMGE Aug 2020.

    Styles: one-liner (1) · vignette (1).

  • Chemotherapy

    Antitubercular and antileprotic drugs

    Seen in 1 of the 19 sessions with recall; 0 of the 11 well-covered sessions.

    First seen: FMGE Dec 2010. Last seen: FMGE Dec 2010.

    Styles: one-liner (1).

All of Chemotherapy, including unseen topics →